Leukemia Exploration and Prevention Grant Program
The Leukemia Exploration and Prevention (LEAP) Grant Program, a partnership between the RUNX1 Research Program and the American Cancer Society, funds investigator-initiated research aimed at discovering cancer interception or prevention therapies for individuals with RUNX1 familial platelet disorder (RUNX1-FPD). RUNX1-FPD is a rare heritable disease caused by germline RUNX1 mutations that confer a 35 to 50% lifetime risk of hematologic malignancies, particularly acute myeloid leukemia. awards $1.9M.
Key Facts
- Award amount
- $1.9M
- Deadline
- Rolling / not specified
- Geography
- National
- Categories
- Research
- Status
- Open
About This Grant
The Leukemia Exploration and Prevention (LEAP) Grant Program, a partnership between the RUNX1 Research Program and the American Cancer Society, funds investigator-initiated research aimed at discovering cancer interception or prevention therapies for individuals with RUNX1 familial platelet disorder (RUNX1-FPD). RUNX1-FPD is a rare heritable disease caused by germline RUNX1 mutations that confer a 35 to 50% lifetime risk of hematologic malignancies, particularly acute myeloid leukemia. The...
Full requirements and application instructions: official listing.